FOLH1 and prostate carcinoma: These findings show that despite the unclear role of PSMA PET/CT and it’s increased sensitivity in current urological guidelines, [68Ga]Ga-PSMA-11 PET/CT is already used as diagnostic tool for primary staging and therapy decision of prostate cancer by clinicians.